The U.S. new cases 7-day rolling average are 15.7 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 10.0 %
LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 5.4 %
HIGHER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 168,620
U.S. Coronavirus hospitalizations are at an elevated 104,303
U.S. Coronavirus deaths are at an elevated 4,000
U.S. Coronavirus immunizations have been administered to 7.9 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases worsened, hospitalizations improved, and deaths improved
Pregnant Women Get Conflicting Advice on Covid-19 Vaccines
The W.H.O. and the C.D.C. provide differing views, and experts partly blame a lack of data because expectant mothers have been excluded from clinical trials.
A pregnant woman being vaccinated in Tel Aviv. The C.D.C. and the W.H.O. differ in their guidance for expectant mothers.Credit.Jack Guez/Agence France-Presse Getty Images
Pregnant women looking for guidance on Covid-19 vaccines are facing the kind of confusion that has dogged the pandemic from the start: The world’s leading public health organizations the U.S. Centers for Disease Control and Prevention, and the World Health Organization are offering contradictory advice.
email article
A widely used arthritis drug reduced the rate of acute graft-versus-host disease (GVHD) in both HLA-matched and -mismatched allogeneic stem-cell transplants, a randomized study showed.
The incidence of grade 3/4 acute GVHD after matched transplants decreased from 14.8% with standard prophylaxis to 6.8% with the addition of abatacept (Orencia). In a small group of patients who had 7/8-HLA-mismatched transplants, grade 3/4 acute GVHD at day 100 declined significantly from 30.2% with standard prophylaxis to 2.3% with add-on abatacept (
P 0.001).
Treatment with abatacept was not associated with increased rates of disease relapse or infection, investigators reported in the We found really striking results, particularly with those who were mismatched stem-cell transplants, in preventing acute GVHD, said Benjamin Watkins, MD, of Aflac Cancer and Blood Disorders Center and Emory University in Atlanta. This was a pretty rigorously run trial . and I think with thes